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ABSTRACT
The tumor suppressor p53 is an essential gene in the induction of cell cycle arrest, 
DNA repair, and apoptosis. p53 protein is induced under cellular stress, blocking 
cell cycle progression and inducing DNA repair. Under DNA damage conditions, it 
has been reported that post-transcriptional regulation of p53 mRNA contributes to 
the increase in p53 protein level. Here we demonstrate that heterogeneous nuclear 
ribonucleoprotein (hnRNP) L enhances p53 mRNA translation. We found that hnRNP 
L is increased and binds to the 5’UTR of p53 mRNA in response to DNA damage. 
Increased hnRNP L caused enhancement of p53 mRNA translation. Conversely, 
p53 protein levels were decreased following hnRNP L knock-down, rendering them 
resistant to apoptosis and arrest in the G2/M phase after DNA damage. Thus, our 
findings suggest that hnRNP L functions as a positive regulator of p53 translation and 
promotes cell cycle arrest and apoptosis.
INTRODUCTION
The p53 gene is the most powerful of the tumor 
suppressor genes [1]. It plays a critical role in DNA 
repair, cell cycle arrest, apoptosis, and senescence, by 
inducing transcription of downstream genes, such as p21, 
Puma, and Bax [2–5]. It was reported that mutations of 
the p53 gene occur in about 50% of human cancers [6]. 
This demonstrates the importance of p53 inhibition in 
tumorigenesis, and how significant the normal function of 
p53 is for anti-cancer effects.
Under normal conditions, p53 protein has a 
short half-life, and is maintained at low levels in the 
cell. However, p53 protein is induced and activated 
for appropriate function following numerous stresses, 
including DNA damage, oxidative stress, and nutrient 
depletion [7–9]. Many studies have demonstrated that 
the stabilization and activation of p53 protein are mainly 
controlled by post-translational regulatory mechanisms 
[10, 11]. However, post-transcriptional regulation is also 
important for finely tuning p53 expression levels in both 
normal and DNA damage conditions. Especially, it has 
been reported that the mechanism of protein synthesis is 
a critical regulation point for the induction of p53 protein 
under cell stress conditions, including DNA damage. 
While irradiation or DNA-damaging reagents cause the 
accumulation of p53 protein, addition of the translation 
inhibitor cycloheximide blocks the induction of p53 
protein, implicating the importance of translation on p53 
protein accumulation [12, 13]. Translation of p53 mRNA 
is regulated by some miRNAs and RNA-binding proteins. 
p53 translation negative regulators including miR-125b, 
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miR-25 and nucleolin inhibit p53 expression and positive 
regulators including HuR and heterogeneous nuclear 
ribonucleoprotein (hnRNP) Q enhance p53 expression and 
p53-mediated apoptosis and cell cycle arrest [12, 14–18].
In the translation process, translation initiation is the 
rate-limiting step [19, 20]. Translation initiation occurs by 
cap-dependent and cap-independent mechanisms [21]. 
Cap-independent translation occurs by a mechanism of 
direct recruitment of ribosome subunits, called internal 
ribosome entry site (IRES)-mediated translation. IRES-
mediated translation is associated with diverse cellular 
conditions like cell differentiation, proliferation, circadian 
rhythm, and apoptosis [22–24]. In particular, it has been 
reported that several proteins involved in cellular stress 
are synthesized by IRES-mediated translation because 
cap-dependent translation is blocked under cellular stress 
conditions [25]. In numerous stress conditions, p53 gene 
expression must be enhanced to activate the pathway for 
DNA repair and cell death. Thus, under stress conditions, 
p53 mRNA can be translated in an IRES-mediated 
manner [26, 27]. The 5’UTR of p53 mRNA has an IRES 
element, and its IRES activity is enhanced by several 
IRES trans-acting factors (ITAFs) [28, 29]. Inhibition of 
ITAFs decreases the translation rate of p53 mRNA and 
p53-mediated apoptosis [17], supporting IRES-mediated 
translation as an important mechanism in p53 regulation.
Heterogeneous nuclear ribonucleoprotein (hnRNP) 
L is an RNA-binding protein enriched in the nucleus. 
hnRNP L binds to CA-repeat and CA-rich RNA elements 
and plays an important role in post-transcriptional 
regulatory mechanisms like pre-RNA splicing, mRNA 
degradation, mRNA export, and IRES-mediated 
translation [30–34]. It can translocate between the nucleus 
and cytosol in response to stress stimulation such as 
hypoxia, and the localization of hnRNP L is critical for its 
specific function [35]. According to catalogue of somatic 
mutation in cancer (COSMIC) database, hnRNP L gene 
is mutated in cancers. It suggests that mutated hnRNP L 
may be exploited by cancer to lead to tumorigenesis. Here, 
we provide evidence that hnRNP L is a new ITAF for the 
translation of p53 mRNA. It associates with the 5’UTR 
of p53 mRNA, and functions as a positive regulator of 
p53 translation. Moreover, we show that hnRNP L knock-
down blocks protein synthesis of p53, which inhibits cell 
apoptosis and cell cycle arrest induced by treatment with 
the DNA-damaging drug etoposide.
RESULTS
DNA damage-induced hnRNP L enhances the 
induction of p53 protein
It is well-known that the accumulation of p53 protein 
after treatment with the DNA-damaging drug etoposide 
is induced through increases in both protein stability and 
protein synthesis [17, 36]. Accumulation of p53 protein 
in nontumorigenic mouse fibroblast NIH3T3 and mouse 
melanoma B16F10 cells was detectable after treatment 
with etoposide (Figure 1A, 1B). However, the amount of 
p53 mRNA remained stable in the total cell extracts and 
cytosolic lysates (Supplementary Figure 1A, 1B and 1C). 
To investigate the possible factors that might regulate the 
accumulation of p53 protein under cell stress conditions, 
we used the RNA-binding protein (RBP)-target interaction 
prediction web server, RBPmap (http://rbpmap.technion.
ac.il/). Among the several candidate factors which are 
expected to bind to p53 mRNA, hnRNP L was reported 
to be involved in regulation of genes related to cell stress 
and cancer [34, 35]. Moreover, we found that hnRNP L 
expression is changed in the presence of etoposide. The 
level of hnRNP L protein increased 2 hours after etoposide 
treatment (Figure 1A, 1B). In NIH3T3 cells treated with 
etoposide, hnRNP L expression in the cytoplasmic fraction 
increased within 30 minutes (Figure 1C), suggesting 
that hnRNP L may control p53 expression. To confirm 
this possibility, we investigated the effect of hnRNP L 
on the expression and induction of p53. Interestingly, 
overexpression of flag-tagged hnRNP L upregulated the 
level of p53 protein in both NIH3T3 and B16F10 (Figure 
1D, 1E). Moreover, knock-down of hnRNP L suppressed 
accumulation of p53 protein, both in normal and DNA-
damaged cells (Figure 1F, 1G). These results show that 
DNA damage-induced hnRNP L positively regulates the 
expression of p53.
hnRNP L increases translation of p53 mRNA
To define the precise role of hnRNP L on p53 
regulation, we tested whether hnRNP L contributes to p53 
protein accumulation through enhanced transcription or 
mRNA stabilization. First, we investigated the effect of 
hnRNP L silencing on endogenous p53 mRNA levels. The 
reduction of hnRNP L did not change the levels of p53 
mRNA in NIH3T3 and B16F10 cells treated with or without 
etoposide (Figure 2A, 2B). This result means that the decline 
in p53 protein accumulation in the hnRNP L-silenced cell 
is not due to reduced levels of p53 mRNA. Many studies 
have reported that the stability of p53 protein is increased 
in various cellular stress conditions, and is important for 
its accumulation [11, 37]. Therefore, we investigated 
p53 protein stability after knock-down of hnRNP L. We 
measured p53 protein stability in control and hnRNP L 
siRNA transfected etoposide-treated NIH3T3 cells with 
cycloheximide treatment. The levels of p53 protein were 
reduced rapidly and to a similar degree in both cells after 
treatment with cycloheximide (Figure 2C, 2D). These results 
indicate that hnRNP L has little or no effect on p53 protein 
stability in both NIH3T3 and B16F10 cells.
Based on previous reports of the importance 
of translation for p53 protein accumulation, we also 
investigated the contribution of the translation process on the 
accumulation of p53 in the presence of the DNA-damaging 
drug, etoposide [12, 17]. Addition of the transcription 
inhibitor actinomycin D did not affect the accumulation 
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of p53 protein, whereas treatment with cycloheximide 
following etoposide treatment completely diminished 
the induction of p53 protein (Supplementary Figure 2A). 
Therefore, we tested whether hnRNP L increases the 
translation efficiency of p53 mRNA. The rate of p53 protein 
synthesis was examined in control and hnRNP L siRNA 
transfected cells after treatment with MG132, a proteasome 
inhibitor. Knock-down of hnRNP L led to a dramatic decline 
in p53 protein accumulation, suggesting the possibility that 
hnRNP L facilitates the translation of p53 mRNA (Figure 
2E). Next, we measured newly synthesized p53 proteins in 
metabolically labeled NIH3T3 cells transfected with control 
or hnRNP L siRNA. Compared to control transfected cells, 
hnRNP L knock-down decreased de novo p53 protein 
synthesis, without changing total protein levels in the cell. 
This strongly suggests that hnRNP L functions to promote 
the translation rate of p53 mRNA (Figure 2F).
IRES activity of p53 mRNA is enhanced by 
hnRNP L
It has been shown that IRES-mediated translation 
makes an important contribution to p53 protein synthesis 
[17, 38]. In addition, several studies have reported that 
Figure 1: Accumulation of p53 is enhanced by an increase in hnRNP L after DNA damage-inducing drug treatment. 
(A, B) Endogenous mouse p53 and hnRNP L are induced after etoposide treatment. (A) NIH3T3 and (B) B16F10 cells were treated with 
100 μM etoposide for the indicated times. Treatment with dimethylsulfoxide (DMSO) for 10 h was used as vehicle control (Veh). The levels 
of endogenous proteins were analyzed by western blotting (WB) using anti-p53, anti-GAPDH, anti-hnRNP L and anti-γH2AX antibodies. 
The housekeeping protein, GAPDH was used as loading control. (C) Protein level of cytosolic hnRNP L increases after treatment with 
etoposide. NIH3T3 cells were fractionated into cytosol and nucleus after exposure to 100 μM etoposide. hnRNP L protein levels of 
fractionated cytosolic lysate were determined by WB using anti-hnRNP L antibody. GAPDH protein was used as loading control and 
cytosol marker. Lamin B protein was analyzed as nucleus marker. DMSO treatment for 4 h was used as vehicle control. Nu, Nuclear lysate. 
The numbers at the bottom mean the fold increases relative to control. The amount of hnRNP L was normalized to GAPDH. (D, E) hnRNP 
L overexpression results in increased p53 protein. Flag-tagged hnRNP L was transfected on (D) NIH3T3 and (E) B16F10 cells. Flag-tagged 
hnRNP L overexpression was confirmed by WB using anti-Flag antibody. (F, G) Induction of p53 is impaired on both (F) NIH3T3 and 
(G) B16F10 cells by knock-down of hnRNP L after 100 μM etoposide treatment. Knock-down of hnRNP L was confirmed by WB using 
anti-hnRNP L antibody.
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Figure 2: hnRNP L controls the expression of p53 through translational regulation. (A, B) hnRNP L does not affect 
endogenous p53 mRNA levels in either normal or DNA-damaged cells. Control siRNA or hnRNP L siRNA was transfected into (A) 
NIH3T3 and (B) B16F10 and cells treated with 100 μM etoposide for 1 hour and 4 hours, respectively. Endogenous p53 mRNA levels were 
analyzed by quantitative real-time PCR (qRT-PCR) and normalized to β-actin. The bars represent the mean±SEM (n=3). (C, D) Knock-
down of hnRNP L does not affect p53 protein stability. After 100 μM etoposide was added to (C) NIH3T3 and (D) B16F10 cells, 50 μg/ml 
cycloheximide (CHX) was then added for the indicated times. Endogenous p53 levels and knock-down of hnRNP L were determined by 
WB. The amount of p53 protein was normalized to GAPDH. p53 protein levels of 0 time point and control siRNA transfected cells were set 
as 1. Data show relative p53 protein intensity from four independent experiments (mean±SEM). (E) hnRNP L increases the translation rate 
of p53 mRNA. After transfection with control or hnRNP L siRNA, 10 μM MG132 was added for the indicated times. Changes in the levels 
of p53 protein by translation or knock-down were assessed by WB. (F) Metabolic labeling shows that reduction of hnRNP L downregulates 
protein synthesis of p53. After transfection of NIH3T3 cells with control or hnRNP L siRNA, cells were incubated in medium containing 
35S-labeled methionine (35S-Met) and 35S-labeled cysteine (35S-Cys) and 10 μM MG132. Newly synthesized p53 proteins were detected 
after immunoprecipitation (IP) with monoclonal p53 antibody. The numbers at the bottom of the first lane mean the fold increases relative 
to control. Data information: In (A-D); Two-way ANOVA
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under conditions of stress, IRES-mediated translation 
of p53 mRNA is enhanced, and contributes to the 
elevation of p53 protein levels [13]. The importance of 
IRES-mediated translation of p53 mRNA was confirmed 
by our next experiment. When the cells were treated 
with rapamycin and etoposide, only a slight decline 
of p53 induction was observed, unlike the case with 
cycloheximide (Supplementary Figure 2B). Rapamycin 
was used to inhibit cap-dependent translation as a main 
inhibitor of mTOR and the activity was confirmed by 
measuring phosphorylation status of S6 ribosome proteins. 
This result means that cap-independent translation of p53 
mRNA is needed for p53 protein induction. Moreover, 
since it was reported that hnRNP L functions as an ITAF 
enhancing the IRES-mediated translation of Cat-1 [34], we 
investigated further whether hnRNP L enhances the IRES-
mediated translation of p53 by utilizing a pRF bicistronic 
luciferase vector. Because the IRES-mediated translation 
of p53 mRNA is induced through the 5’UTR, the 5’UTR 
of mouse p53 was inserted into the vector between the 
Renilla luciferase (RLUC) and firefly luciferase (FLUC) 
cistrons (Figure 3A). RLUC translation is cap-dependent, 
whereas FLUC translation is cap-independent. The IRES 
activity is calculated by the ratio of FLUC to RLUC. 
As reported earlier, IRES activities are dramatically 
increased by mouse p53 5’UTR [17]. When hnRNP L 
was overexpressed, the IRES activities were enhanced by 
about 70% (Figure 3B). Conversely, when the hnRNP L 
level was reduced, IRES activities of p53 5’UTR declined 
significantly in both NIH3T3 and B16F10 cells (Figure 
3C, 3D). This observation validated the functional role 
of hnRNP L as an ITAF that enhances the translation of 
p53 mRNA. Next, we evaluated the impact of hnRNP L 
on IRES-mediated translation of p53 mRNA under stress 
conditions. We transfected the pRF p53 5’UTR vector 
into control siRNA and hnRNP L siRNA transfected 
cells, and subsequently treated them with control solvent 
(DMSO) or etoposide. As expected, in the control siRNA 
transfected cells, IRES-mediated translation of p53 mRNA 
increased by about 40% in cells incubated with etoposide 
compared to cells treated with DMSO. However, such a 
rise in IRES activities was diminished by knock-down of 
hnRNP L (Figure 3E). These data indicate that hnRNP L 
plays a key factor to increase IRES-mediated translation 
of p53 mRNA and accumulation of p53 protein under 
normal and DNA-damaging conditions. We previously 
found that hnRNP Q functions as an ITAF of p53 mRNA 
[17]. To test whether hnRNP L and hnRNP Q affect each 
other’s function for the IRES-mediated translation of p53 
mRNA, we analyzed the IRES activities of p53 5’UTR 
under knock-down of hnRNP L and hnRNP Q. p53 IRES 
activity in cells transfected with both sihnRNP Q and 
sihnRNP L was comparable with that in cells transfected 
with either sihnRNP Q or sihnRNP L (Supplementary 
Figure 3A). This result reveals that hnRNP L and hnRNP 
Q work closely together to enhance the IRES-mediated 
translation of p53 mRNA.
hnRNP L functions as an ITAF by binding to p53 
mRNA
The binding of hnRNP L to the 5’UTR of p53 
was investigated using an in vitro binding assay. We 
found that hnRNP L was bound by biotinylated-p53 
5’UTR, and this binding was reduced by competition 
with unlabeled-p53 5’UTR (Figure 4A, 4B). In the 
control, the binding of GAPDH to the p53 5’UTR was 
undetectable. Thus, the interaction of hnRNP L with the 
5’UTR of p53 mRNA is a specific interaction. Moreover, 
to verify that the interaction occurs in the cytoplasm 
where translation of mRNAs occurs, biotinylated-p53 
5’UTR transcripts were incubated with either cytoplasm 
or nucleus fraction from NIH3T3 cells. We observed 
that the p53 5’UTR associates with hnRNP L in both 
cytoplasm and nucleus (Supplementary Figure 4A). 
When we tested whether coding region and 3’UTR of 
p53 mRNA bind to hnRNP L, hnRNP L preferentially 
binds to 5’UTR and 3’UTR rather than coding region 
of p53 mRNA (Supplementary Figure 4B). Next, 
to confirm whether binding of hnRNP L and 5’UTR 
of p53 mRNA is direct or indirect, we performed 
an in vitro binding assay using purified hnRNP L 
protein and biotinylated-p53 5’UTR. We verified that 
the association of hnRNP L and p53 5’UTR is direct 
(Figure 4C). Furthermore, to confirm the effect of 
DNA damage on the binding of hnRNP L to the p53 
5’UTR, we performed in vitro binding assays using 
cytoplasmic extracts of NIH3T3 cells treated with 
etoposide. As a result, the association of hnRNP L and 
p53 5’UTR became stronger under conditions of DNA 
damage (Figure 4D). Next, we confirmed an interaction 
between endogenous hnRNP L and p53 mRNA using 
RNA-immunoprecipitation (RNAIP). hnRNP L antibody 
enabled us to have immunoprecipitation of p53 mRNA 
about 3.5-fold compared with control IP reactions using 
IgG. Under stressed condition, the association of hnRNP 
L and p53 mRNA was increased (Figure 4E). We tried 
to identify the region within the p53 mRNA 5’UTR that 
contributes to hnRNP L binding using the pRF vectors 
containing serially deleted 5’UTR of p53 (Figure 4F). 
The chimeric reporter vectors were transfected into 
NIH3T3 cells and RNAIP was performed using hnRNP 
L antibody and control IgG. This analysis showed that 
hnRNP L preferentially binds to the p53 5’UTR 1-157 
chimeric transcripts, while the interaction with p53 
5’UTR 110-157 chimeric transcripts is weak. This 
result suggests that the region between nucleotides 87 
and 109 within p53 5’UTR is important for association 
of hnRNP L. The results of the binding assay correlated 
with the decrease in the IRES activity test using the pRF 
bicistronic vector containing serially deleted nucleotides 
(Figure 4G). To confirm the interaction reciprocally, 
hnRNP L was pulled down by serially deleted 
biotinylated-p53 5’UTR transcripts. As a consequence, 
the binding of hnRNP L with p53 5’UTR disappeared in 
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the 109 nucleotides deleted construct, supporting that 
the binding region of hnRNP L lies between nucleotides 
87 and 109 of the p53 5’UTR (Figure 4H). hnRNP L 
was reported to preferentially bind to CA-rich regions, 
and to be involved in the regulation of RNA containing 
CA-rich elements [39]. Interestingly, examination of 
the p53 5’UTR sequence revealed a region between 
nucleotides 100 and 105 with the sequence CAUUCA 
which is reported to interact strongly with hnRNP L 
(Supplementary Figure 4C) [40]. This sequence was 
considered as the binding site for hnRNP L. To test this 
hypothesis, we generated p53 5’UTR mutant containing 
GUAAGU substitution instead of CAUUCA sequences. 
We found that CAUUCA sequences is an important 
Figure 3: hnRNP L enhances IRES activity of p53 5’UTR. (A) Schematic representation of the bicistronic luciferase pRF plasmids 
used for the detection of p53 5’UTR IRES activity. The 157bp p53 5’UTR was inserted between the two cistrons, Renilla luciferase (RLUC) 
and firefly luciferase (FLUC). (B) IRES activity of p53 5’UTR is increased under hnRNP L overexpression. NIH3T3 cells were transfected 
with flag Mock or flag hnRNP L and 24 h later with pRF mock vector or pRF p53 5’UTR vector. Luciferase activity is shown as the ratio of 
FLUC to RLUC and IRES activity of pRF mock and flag Mock transfected cells was set as 1. The bars represent the mean±SEM (n=3). (C, 
D) Suppression of p53 5’UTR IRES activity is observed after knock-down of hnRNP L. At 24 h after transfection with control or hnRNP 
L siRNA, pRF mock or pRF mp53 5’UTR vector was transfected into (C) NIH3T3 and (D) B16F10 cells. IRES activity of pRF mock and 
control siRNA transfected cells was set as 1. The bars represent the mean±SEM (n=7, n=4). (E) Increase of p53 5’UTR IRES activity under 
etoposide treatment is diminished through the reduction of hnRNP L. Cells were transfected with pRF p53 5’UTR at 24 h after transfection 
with either control or hnRNP L siRNA, and DMSO or etoposide was added at 18 h after transfection. IRES activity of control siRNA 
transfected and DMSO treated NIH3T3 cells was set as 1. The bars represent the mean±SEM (n=7). Data information: In (B–E), n.s., non-
significant, *P<0.05, **P<0.01, ****P<0.0001(Two-way ANOVA)
Oncotarget51114www.impactjournals.com/oncotarget
Figure 4: hnRNP L interacts with p53 mRNA and the binding apparently increases after DNA damage. (A, B) In 
vitro binding assays were performed by incubating in vitro transcribed biotin-p53 5’UTR with (A) NIH3T3 or (B) B16F10 cell extracts 
and followed by pull down with streptavidin beads. The binding between p53 5’UTR and hnRNP L was confirmed by Western blotting. 
GAPDH was used as negative control. Non-biotinylated p53 5’UTR was used as competitor. (C) hnRNP L directly binds to p53 5’UTR. 
Purified hnRNP L proteins were incubated with in vitro transcribed biotin-p53 5’UTR. (D) Under DNA damage conditions, the amount of 
hnRNP L proteins interacting with p53 5’UTR increases. In vitro transcribed biotin-p53 5’UTR was incubated with cytoplasmic extracts of 
non-treated (Con) or etoposide-treated (Eto) NIH3T3 cells. hnRNP U was used as negative control and GAPDH was used as loading and 
negative control. The numbers at the bottom mean the fold increases relative to control. (E) Endogenous hnRNP L binds endogenous p53 
mRNA and the binding increases under etoposide treatment. Lysates of non-treated (Control) and etoposide treated (Etoposide) NIH3T3 
cells were used for RNA-immunoprecipitation (RNAIP) analysis using IgG control and hnRNP L antibody. RNA abundance in IP samples 
was determined by qRT-PCR. The levels of p53 mRNA were normalized to GAPDH mRNA levels. p53 mRNA level in control-IgG sample 
was set as 1. The bars represent the mean±SEM (n=3). (F) hnRNP L binds to p53 5’UTR 1-109 region. pRF Mock, pRF p53 5’UTR 1-157 
or pRF p53 5’UTR 110-157 vector was transfected into NIH3T3 cells. 24h later, cells were lysed and the lysates were used for RNAIP 
using control IgG and hnRNP L antibody. RNA abundance was determined by qRT-PCR. The levels of FLUC mRNA in IP samples were 
normalized to input FLUC mRNA levels. FLUC mRNA level in control IgG sample of the pRF Mock transfected cells was set as 1. The 
bars represent the mean±SEM (n=4). (G) The region between nucleotides 87 and 109 of p53 5’UTR is important for IRES activity of 
p53 5’UTR. To confirm IRES activities of serial deletion constructs, luciferase assay was carried out. Luciferase activity is shown as the 
ratio of FLUC to RLUC. IRES activity of p53 5’UTR 1–157 full length construct was set as 1. The bars represent the mean±SEM (n=3). 
(H) To identify the binding region of hnRNP L to the 5’UTR of p53 mRNA, in vitro binding assays were conducted. Biotin-labeled p53 
5’UTR constructs were incubated with NIH3T3 cell extracts. The interaction of p53 5’UTR and hnRNP L was verified by Western blotting. 
GAPDH was used as negative control. Data information: In (E-G), *P<0.05 (Two-way ANOVA).
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binding region of hnRNP L as p53 5’UTR mutant binds 
very weakly to hnRNP L (Figure 4H). Taken together, 
hnRNP L binds to p53 5’UTR and positively regulates 
p53 translation.
Reduction of hnRNP L suppresses cell cycle 
arrest and cell apoptosis induced by DNA 
damage
p53 gene is well-known to regulate cell cycle 
progression and apoptosis by functioning as a transcription 
factor [3]. In this study, we have confirmed the reduction 
of p53 protein by hnRNP L silencing. Therefore, we 
determined whether the mRNA levels of p53 downstream 
target genes are also decreased by knock-down of hnRNP 
L. NIH3T3 cells were transfected with control or hnRNP 
L siRNA, and then incubated with or without etoposide. 
When NIH3T3 cells were exposed to etoposide, the 
mRNA levels of p53 target genes, p21, Mdm2, Puma, 
increased compared to the untreated cells (Figure 5A). 
Under normal conditions, hnRNP L knock-down had no 
effect on expression of each target gene. However, in cells 
exposed to the DNA-damaging agent, knock-down of 
hnRNP L resulted in reduced mRNA expression of p21, 
Mdm2 and Puma compared to control siRNA transfected 
cells. This result suggests the possibility that hnRNP L 
knock-down may control cell cycle and DNA-damaging 
drug-induced apoptosis because p21 is a key regulator 
controlling cell cycle, and Puma is a proapoptotic gene 
[41, 42]. Therefore, we tested whether p53 accumulation 
lowered by hnRNP L knock-down affects cell cycle arrest 
in cell stress conditions. In the presence of etoposide, the 
cell cycle was arrested at S phase and G2/M as reported 
previously (Figure 5B and Supplementary Figure 5A) [18]. 
Cell cycle analysis showed that there were fewer cells at 
G2/M phase in hnRNP L siRNA transfected cells than in 
control cells, though no difference was seen at S phase. 
Moreover, though extended treatment with etoposide led 
to accumulation of more cells at sub G1, an indicator of 
apoptosis-induced DNA fragmentation, the number of 
cells at sub G1 was reduced when hnRNP L was knocked 
down, indicating that decreased hnRNP L expression 
alleviates cell death (Figure 5C and Supplementary 
Figure 5A). Therefore, reduction of hnRNP L seems 
to relieve cell cycle arrest in G2/M phase and decrease 
cell death. The effect of hnRNP L on cell death was also 
determined by MTT assay. At 12 hours and 18 hours after 
exposd to etoposide, cell viability increased by about 
15% by silencing of hnRNP L (Figure 5D). To confirm 
that the increased cell viability by reduced hnRNP L was 
a p53-mediated outcome, MTT assays were carried out 
on immortalized fibroblasts from a p53/Mdm2 deficient 
mouse. hnRNP L knock-down had no effect on cell 
survival in the absence of p53, indicating that hnRNP L 
reduces cell viability by increasing the level of p53 protein 
(Figure 5E). Next, to determine that the effect of hnRNP 
L on DNA damage-induced apoptosis was not due to 
necrosis, activation of caspase3, an executioner caspase, 
was analyzed and terminal deoxynucleotidyl transferase 
dUTP nick end labeling (TUNEL) assays were performed. 
Our results show that the active (cleaved) form of caspase3 
was decreased in cells with decreased hnRNP L (Figure 
5F). Moreover, we confirmed that lowered hnRNP L 
expression attenuated etoposide induced apoptosis, which 
was verified by the reduced number of TUNEL-positive 
cells (Figure 5G, 5H). Taken together, these data indicate 
that hnRNP L elevates DNA damage-induced apoptosis.
DISCUSSION
In this study, we have identified that hnRNP L 
increases the IRES-mediated translation of p53 mRNA. 
Etoposide treatment promoted hnRNP L accumulation and 
this contributed to the induction of p53. hnRNP L activates 
the translation of p53 mRNA by binding each other and 
this binding is increased in response to DNA damage. We 
found that the reduction of hnRNP L expression blocks 
the translation of p53 mRNA and the accumulation of p53 
protein. Along with this, decreased hnRNP L alleviated 
DNA damage-mediated apoptosis and cell cycle arrest at 
G2/M phase (Figure 6).
Etoposide treatment triggered an increase in hnRNP 
L expression that could be observed in the cytoplasm 30 
minutes after treatment (Figure 1A, 1B and 1C). This 
suggests the possibility that hnRNP L translocates from the 
nucleus to the cytoplasm in response to DNA damage. In 
fact, it has been suggested that hnRNP L carries a nuclear 
localization signal (NLS) and a nuclear export signal 
(NES)-similar sequence, and is involved in the transport 
of target mRNAs [43]. In addition, it was reported that 
external stresses induce the translocation of hnRNP L to 
the cytoplasm for the regulation of mRNA stability and 
translation [31, 34, 35]. Taken together, these data indicate 
that hnRNP L may be transported to the cytoplasm under 
cell stress conditions, to regulate at the post-transcriptional 
level of those mRNAs which are important for cell 
survival. At the total protein level, not only hnRNP L 
but also p53 peak at 2 hours in NIH3T3 cells after drug 
treatment and remain steady. However, increased hnRNP 
L expression ceases, and hnRNP L protein levels seem to 
return to the basal levels, with long term exposure to high 
concentrations of etoposide (Figure 1A and 5F). We found 
that under these conditions, the total cell levels of hnRNP 
L proteins are the same at 0 and 18 hours points (Figure 
5F), although we did not examine the cytoplasmic level 
of hnRNP L. Even though the cytoplasmic hnRNP L does 
not remain elevated under long exposure to etoposide, the 
increase in p53 remains constant. This may be due to post-
translational modification of hnRNP L. It was suggested 
that phosphorylation of hnRNP L enhances or weakens 
the binding affinity for target mRNAs [44]. Thus, post-
translational modification of hnRNP L under DNA damage 
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Figure 5: Reduction of hnRNP L downregulates p53 expression and relieves cell cycle arrest and DNA damage-induced 
apoptosis of NIH3T3 cells. (A) mRNA levels of p53 target genes including p21, Mdm2 and Puma decrease in NIH3T3 cells transfected 
with hnRNP L siRNA and under etoposide treatment. At 24 h after transfection with control or hnRNP L siRNA, NIH3T3 cells were treated 
with or without 100 μM etoposide for 12 h. The levels of p21, MdmM2 and Puma mRNAs were analyzed by qRT-PCR and normalized 
to RPL32 mRNA levels. mRNA levels in control siRNA transfected and non-etoposide treated cells were set as 1. The bars represent the 
mean±SEM (n=5). (B, C) hnRNP L silencing lowers p53-mediated G2/M arrest and cell death. At 24 h after transfection with control or 
hnRNP L siRNA, NIH3T3 cells were treated with 50 μM etoposide for the indicated times and stained with DNA dye, propidium iodide 
(PI). The data were analyzed by flow cytometry. The bars represent the mean±SEM (n=4). (D) Reduction of hnRNP L increases cell 
viability. Control siRNA or hnRNP L siRNA transfected cells were exposed to 50 μM etoposide for the indicated times and the cell viability 
was assessed by MTT assay. The graph represents the mean±SEM (n=3). (E) In immortalized fibroblasts from p53/Mdm2 double-knockout 
mouse, hnRNP L does not affect cell viability. 50 μM etoposide was added to p53/Mdm2 double-knockout mouse fibroblasts transfected 
with siCon or sihnRNP L and MTT assay was conducted for measurement of cell viability. The graph represents the mean±SEM (n=3). 
(F) p53 expression is suppressed by knock-down of hnRNP L, which reduces activation and cleavage of caspase 3. Transfected cells 
were treated with 50 μM etoposide for the indicated times. Knock-down of hnRNP L was confirmed by WB. (G, H) Cell apoptosis was 
suppressed by hnRNP L knock-down. TUNEL assay was performed in cells transfected with control or hnRNP L siRNA and treated with 
100 μM etoposide for 48 h. Nuclei were stained with Hoechst 33342. (G) Representative image from four independent experiments. (H) 
The diagram shows relative apoptotic cells measured by TUNEL assay. The bars represent the mean±SEM (n=4). More than 700 cells were 
analyzed in both group. The number of TUNEL-positive cells in control siRNA transfected cells was set as 1. Data information: In (A-E, 
H), *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 (Two-way ANOVA, Student’s t-test).
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conditions needs to be investigated. Another possibility is 
the contribution of some other factors to the control of 
p53 expression. Previously described post-translational 
and translation regulators of p53 must be considered, since 
a complex series of interactions may be involved in the 
delicate regulation of p53 expression.
We confirmed the effect of hnRNP L on cell cycle 
arrest after DNA damage. Cell cycle arrest was relieved at 
G2/M phase not at S phase when hnRNP L was silenced 
(Figure 5B). We can postulate several possibilities for 
this result. First, we assume that hnRNP L knock-down is 
more effective at G2/M phase when high induction of p53 
protein occurs. We have already reported that p53 protein 
levels are higher in the G2/M arrested cell than in the G1 
and S phase arrested cells, and the accumulation rate of 
p53 is enhanced at G2/M. In support of our assumption, 
IRES activity of human and mouse p53 mRNA is reported 
to be higher at G2/M [17, 38]. Another possibility is that 
hnRNP L knock-down influences the expression of other 
cell cycle regulators in addition to p53. As mentioned 
earlier, hnRNP L affects splicing, mRNA transport, 
translation, protein localization. Therefore, the potential 
roles of hnRNP L on other cell cycle regulators need to 
be considered.
We determined that hnRNP L has no impact on 
protein stability of p53 in both NIH3T3 and B16F10 cells 
(Figure 2C, 2D), but rather, stimulates the translation 
of p53 mRNA (Figure 2F). However, this finding is 
contrary to others that hnRNP L functions as an inhibitory 
binding partner of p53 protein in embryonic mouse stem 
cell (mESC) [45, 46]. We already know that the unique 
environment of each cell type affects cell specificity in 
transcription, splicing, and stability, and numerous genes 
have cell-type specific expression. Further, genes can 
function in a cell-type specific manner. For example, 
p18 is a known tumor suppressor, but accelerates cell 
growth of mESC in contrast to tumor and adult stem cells 
[47]. Therefore, factors that interact with hnRNP L may 
depend on cell type, which may in turn alter the functions 
mediated by hnRNP L. Furthermore, it is necessary to 
investigate and consider the complex and diverse functions 
of hnRNP L in diverse situations.
p53 is one of main regulatory genes for 
maintaining genomic integrity and cell survival. 
Abnormally low expression of p53 is associated with 
cell transformation and tumorigenesis, whereas its 
elevated expression induces cell death and inhibition 
of cell growth [48, 49]. Thus, it is important for p53 
to be well regulated and expressed at the well-balanced 
level to maintain the integrity and survival of the cell. 
Because of this, regulatory mechanisms of p53 gene 
expression has been importantly studied. In case of 
p53 mRNA translation, several regulatory factors 
including miRNAs and RNA-binding proteins were 
found. miR-125b and miR-504 inhibit translation of 
p53 mRNA and apoptosis by binding to p53 3’UTR 
Figure 6: Model for p53 IRES-mediated translation activated by hnRNP L in normal and DNA damage conditions. 
hnRNP L positively regulates IRES-mediated translation of p53 mRNA. Under DNA damage condition, hnRNP L translocates from the 
nucleus to the cytoplasm in early times and hnRNP L expression also increases. Increased hnRNP L elevates IRES-mediated translation of 
p53 mRNA and increased p53 proteins induce apoptosis in DNA damaged cells.
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and increase tumorigenesis [14, 15]. It is also reported 
that hnRNP Q, RPL26, and PTB enhance p53 mRNA 
translation by binding preferentially to p53 5’UTR and 
elevate cell apoptosis and cell cycle arrest [12, 17, 29]. 
Likewise, hnRNP L functions as a positive regulator 
of p53 translation and increases cell apoptosis and cell 
cycle arrest under DNA damage condition. Under DNA 
damage condition or cancer developing environment, 
expression level, localization and activity of these 
factors seem to change and these changes regulate 
translation of p53 and cell fate. Though various cellular 
environments must be considered, it may be helpful for 
cancer therapy to control regulators of p53 translation.
MATERIALS AND METHODS
Plasmid and RNA interference
Bicistronic pRF p53 5’UTR vector for luciferase 
assay and pSk p53 5’UTR vector for in vitro binding 
assay were made by inserting the mouse p53 (accession 
no. NM_011640.3) 5’UTR as described previously [17]. 
Forward primer 5'-AAAAGCTTATGTCGCGGAGGCTG
CTGC-3' and reverse primer 5'-CCGGATCCTTAGGAGG
CGTGCTGAGC-3' (Macrogen, Seoul, Repulic of Korea) 
were used to make Flag-tagged hnRNP L.
The used siRNA duplex was as follows; Control 
5’-CCUACGCCACCAAUUUCGUdTdT-3’ (Bioneer, 
Daejeon, Republic of Korea), Mouse hnRNP L #1 
5’-GAUGAACUGUGAUCGAGUCdTdT-3’ (Bioneer). 
Mouse hnRNP L #2 5’-GAACGGAGUUCAGGCU 
AUGdTdT-3’ (Bioneer) is modified form from previously 
reported human hnRNP L siRNA [50].
Cell culture and transient transfection
Mouse fibroblast NIH3T3 cells were cultured 
in Dulbecco's Modified Eagle's medium (DMEM; 
Hyclone) supplemented with 10% fetal bovine serum 
(FBS; Hyclone) and 1% penicillin/streptomycin. Cells 
were maintained in 5% CO2 at 37°C. The immortalized 
fibroblasts from p53/Mdm2 double-knockout mice, a 
gift from Dr. Jaewhan Song (Yonsei University, Seoul, 
Korea), and mouse melanoma B16F10 cells were grown 
in DMEM (Welgene) supplemented with 10% FBS 
(Welgene) and 1% penicillin/streptomycin. siRNAs 
and Flag vector were transfected into cells using the 
Neon microporation system (Invitrogen). At 24 h after 
this transfection, transfection of the pRF vectors was 
performed using Lipofectamine 2000 (Invitrogen) 
according to manufacturer’s instructions. Cells were 
harvested after 24 h incubation.
Protein expression and purification
Competent E.coli BL21(DE3) cells were 
transformed with vectors coding for Intein-hnRNP L and 
were grown. Proteins were induced by isopropyl β-D-1-
thiogalactopyranoside (IPTG) at 18°C overnight. Cells 
were resuspended with Intein binding buffer (20mM Tris-
HCl (pH8.0), 200mM NaCl, protease inhibitor) and lysed 
by sonicator. Cell extracts were incubated with chitin 
beads at 4°C overnight and then the beads were incubated 
with elution buffer (20mM Tris-HCl (pH8.0), 200mM 
NaCl, 50mM DTT) at 4°C overnight.
Dual luciferase reporter assay
Cells harvested 24 h after transfection of the 
bicistronic pRF vector were lysed in 50 μl Reporter Lysis 
5XBuffer (Promega). Luciferase activities of the samples 
were measured twice using the Dual-Luciferase Reporter 
Assay System (Promega) and luminometer according to 
the manufacturer’s instructions.
In vitro binding assay
pSK 5’UTR constructs including serially deleted 
p53 5’UTR (1–157, 87–157, 110–157, 87-109) and p53 
5’UTR mutation were linearized with XbaI restriction 
enzyme. The linearized constructs were transcribed 
by T7 polymerase (Promega) in the presence of biotin-
UTP (Roche) and then treated with DNase I (Promega) 
to remove DNA. The biotin conjugated RNAs were 
incubated with cell extracts for 30 mins at room 
temperature. Biotin-labeled RNAs and cell extracts were 
incubated with streptavidin beads (Thermo Scientific) at 
4°C overnight. Proteins in the precipitates were detected 
by western blotting.
Flow cytometry assay
NIH3T3 cells treated with 50 μM etoposide (Sigma) 
24 h after transfection with control or hnRNP L siRNA 
were used for cell cycle analysis. Harvested cells were 
washed with and suspended in phosphate-buffered saline 
(PBS) containing 1% Bovine serum albumin (BSA). Cells 
were fixed and permeabilized in 95% ethanol containing 
0.5% Tween-20 at 4°C overnight. After washing with PBS 
containing 1% BSA, cells were incubated with propidium 
iodide (PI) solution and RNaseA for 30 min at 37°C in 
the dark. DNA contents of cells were analyzed by flow 
cytometer (FACS caliber, Becton-Dickinson).
Cell extract preparation and Immunoblotting
Cells were gently harvested and lysed with TNE 
buffer (50 mM Tris, 140 mM NaCl, 5 mM EDTA) 
containing PierceTM Protease Inhibitor (Thermo Scientific) 
and using sonication. Nuclear/cytosolic fractionations of 
NIH3T3 cells were conducted as previously described 
[17]. Proteins were separated on 12% SDS-PAGE gels 
and then transferred to nitrocellulose membrane. For 
protein detection, we used monoclonal anti-p53 (Cell 
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Signaling), monoclonal anti-Flag (Sigma-Aldrich), 
monoclonal anti-hnRNP L (Abcam), polyclonal anti-
GAPDH (Millipore), anti-Lamin B (Santa Cruz), 
anti-cleaved caspase3 (Cell Signaling), anti-phospho-
Histone H2A.X (Ser 139) (Millipore) and Horseradish 
peroxidase (HRP) -conjugated mouse (Thermo Scientific) 
and rabbit (Promega) secondary antibodies. Enhanced 
chemiluminescence (ECL) was detected with the LAS-
4000 system (FUJI FILM).
Metabolic labeling
Metabolic labeling was performed as previously 
described [17]. In brief, NIH3T3 cells were seeded in 10-
cm dishes. At 80% confluency, cells were washed with 
PBS and incubated for 1 h in methionine- and cysteine-
free DMEM (Met-/Cys- DMEM) supplemented with 
10% FBS and 1% antibiotics. The medium was then 
replaced with (Met-/Cys- DMEM) containing 35S-labeled 
methionine (35S-Met) and 35S-labeled cysteine (35S-Cys). 
After 1 h, the cells were harvested and lysed in buffer (20 
mM Tris, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 
1% Triton). Immunoprecipitation was carried out with 
mouse IgG (Santa CruZ Biotechnology) or p53 mouse 
monoclonal antibody overnight.
MTT assay
Cells were seeded onto 96 well plates at a density 
of 10,000 cells per well after transfection with control 
or hnRNP L siRNA, and then treated with 50 μM 
etoposide for 12 h or 18 h. 3-(4, 5-dimethylthiazolyl-
2)-2,5-diphenyltetrazolium bromide (Tetrazolium MTT) 
solution was added to the cells and incubated for 2 h 
at 37°C. MTT crystals were solubilized in DMSO. 
Absorbance was measured at 570 nm (Infinite 200 
NanoQuant, Tecan).
Quantitative Real-time RT-PCR
To extract RNA from cells, we used TRI Reagent 
(Molecular Research Center, Cincinnati, OH, USA). 
Isolated RNA was reverse-transcribed using ImProm-
IITM Reverse Transcription System (Promega). 
FastStart Universal SYBR Green Master (Rox) 
(Roche) was used for qRT-PCR with StepOnePlus 
Real-Time PCR System (Applied Biosystems, 
Carlsbad, CA, USA). The following primers were 
used : For the detection of mouse p53, forward 
5’-GGATGCCCATGCTACAGAGGAGTCT-3’ and 
reverse 5’-GTCTGAGTCAGGCCCCACTTTCTTG-3’ 
; mouse ribosomal protein L32 (mRPL32), forward 
5’-AACCCAGAGGCATTGACAAC-3’ and reverse 
5’-CACCTCCAGCTCCTTGACAT-3’ ; mouse β-actin, 
forward 5’-GGCACCACACCTTCTACAATG-3’ and 
reverse 5’-GGGGTGTTGAAGGTCTCAAAC-3’; p21, 
forward 5’-TTGCACTCTGGTGTCTGAGC-3’ and 
reverse 5’-TCTGCGCTTGGAGTGATAGA-3’; Mdm2, 
forward 5’-TGTGTGAGCTGAGGGAGATG-3’ and 
reverse 5’-ATCCTGATCCAGGCAATCAC-3’; Puma, 
forward 5’- GCTGAAGGACTCATGGTGAC-3’ and 
reverse 5’-CAAAGTGAAGGCGCACTG-3’; FLUC, 
forward 5’-CTCACTGAGACTACATCAGC-3' and 
reverse 5’-TCCAGATCCACAACCTTC GC-3'; mouse 
GAPDH, forward 5’-GCCATCAACGACCCCTTCATT-3’ 
and reverse 5’-GCTCCTGGAAGATGGTGATGG-3’;
RNA-Immunoprecipitation
NIH3T3 cells were treated with or without 100 
μM etoposide and lysed with RNAIP buffer (20mM Tris-
HCl (pH7.5), 100mM KCl, 5mM MgCl2, 0.1% NP40, 
protease inhibitor). Mouse IgG or hnRNP L antibody was 
incubated with NIH3T3 cell lysates at 4°C overnight and 
then incubated with Protein G beads at 4°C for 4hr. We 
washed the beads 3 times with RNAIP buffer and isolated 
RNA using TRI reagent. RNA levels were quantified by 
qRT-PCR.
TUNEL assay
siRNA transfected cells were grown on cover glass 
and exposed to 100 μM etoposide. Cells were fixed in 4% 
paraformaldehyde (Sigma-Aldrich) and permeabilized 
with 0.1% Triton X-100 solution (Sigma-Aldrich). 
Cells were rinsed with PBS, and apoptotic cells were 
detected by incorporation of fluorescein-12-dUTP at the 
fragmented DNA ends. TUNEL assay Kit (DeadEND 
Fluorometric TUNEL system, Promega) was used for 
labeling fragmented DNA according to the manufacturer’s 
instructions. Nuclei of cells were stained with Hoechst 
33342. The fluorescein-12-dUTP-labeled DNA was 
visualized by fluorescence microscopy (OLYMPUS 
1X71).
Statistical analyses
Data are shown as mean±SEM from independent 
experiments. Exact n value is represented in the figure 
legends. One-way, Two-way analysis of variance 
(ANOVA) and paired t-test were done using GraphPad 
Prism. P<0.05 was considered statistically significant. 
P<0.05, P<0.01, P<0.001, and P<0.0001 are indicated 
with *, **, ***, and ****, respectively.
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